Vibe Bio
resources
Case study: Orphan Therapeutics
How Orphan Therapeutics Accelerator is optimizing rare disease search & eval
Learn how Orphan Therapeutics Accelerator uses Vibe Bio for rare disease due diligence, pipeline and competitive analysis, and in-licensing strategy.
Webinar: Watch on-demand
The AI buying guide for BD&L executives
The AI buying guide for Business Development & Licensing (BD&L) executives Webinar on-demand Evaluate & choose AI solutions to achieve real results Your biopharma BD&L teams are under unprecedented pressure…
Additional resources
Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands
This article examines how Vibe Bio’s Founder and CEO is putting drug development into patients’ hands.
Endpoint News – Parents become drug developers to save their children’s lives
Endpoint News addressed how parents of children with rare disease are challenging the status quo in drug development.
Coindesk – How Vibe Bio plans to retool biotech funding
In this article, Vibe Bio founder and CEO, Alok Tayi, explains how a decentralized science approach can retool biotech funding.
No posts
No posts
Whitepaper: The AI buying guide for BD&L executives
AI is already transforming how leading organizations identify, evaluate, and close deals, but not all AI platforms are built for BD&L.
No posts
No posts
No posts
Uncover new possibilities with VibeOne
Learn how VibeOne can help you discover your next indication or identify high potential development opportunities in your portfolio.